10X Genomics Inc Working Capital to Net Assets Ratio
10X Genomics Inc working capital to net assets ratio. 10X Genomics Inc (TXG) has a Working Capital to Net Assets ratio of 67.4% as of June 2026. Working capital of $556.16 Million (current assets of $674.67 Million minus current liabilities of $118.51 Million) is measured against net assets of $825.55 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of 10X Genomics Inc (2017–2025)
Working capital to net assets ratio of 10X Genomics Inc from 2017 to 2025. This chart shows how 10X Genomics Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 67.4%, reflecting working capital of $556.16 Million against net assets of $825.55 Million USD. See TXG cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
10X Genomics Inc Working Capital to Net Assets Ratio by Year (2017–2025)
10X Genomics Inc working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for 10X Genomics Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see TXG asset base.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 66.7% | $531.00 Million | $796.33 Million | $684.45 Million | $153.45 Million | ▲ +1.0 pp |
| 2024 | 65.7% | $466.75 Million | $710.13 Million | $584.39 Million | $117.63 Million | ▲ +2.5 pp |
| 2023 | 63.3% | $468.86 Million | $741.04 Million | $596.02 Million | $127.16 Million | ▲ +0.7 pp |
| 2022 | 62.6% | $504.08 Million | $805.74 Million | $635.03 Million | $130.96 Million | ▼ -15.4 pp |
| 2021 | 77.9% | $637.23 Million | $817.57 Million | $747.59 Million | $110.36 Million | ▼ -10.8 pp |
| 2020 | 88.8% | $656.24 Million | $739.07 Million | $774.37 Million | $118.13 Million | ▼ -10.7 pp |
| 2019 | 99.5% | $417.79 Million | $420.08 Million | $480.84 Million | $63.05 Million | ▲ +133.0 pp |
| 2018 | -33.6% | $73.87 Million | $-219.99 Million | $106.24 Million | $32.36 Million | ▲ +7.3 pp |
| 2017 | -40.9% | $45.97 Million | $-112.51 Million | $68.11 Million | $22.14 Million | — |